TN2013000498A1 - Constructions d'extinction du gene p0 et utilisation - Google Patents

Constructions d'extinction du gene p0 et utilisation

Info

Publication number
TN2013000498A1
TN2013000498A1 TNP2013000498A TN2013000498A TN2013000498A1 TN 2013000498 A1 TN2013000498 A1 TN 2013000498A1 TN P2013000498 A TNP2013000498 A TN P2013000498A TN 2013000498 A TN2013000498 A TN 2013000498A TN 2013000498 A1 TN2013000498 A1 TN 2013000498A1
Authority
TN
Tunisia
Prior art keywords
constructs
extinction
gene
gene extinction
bmyv
Prior art date
Application number
TNP2013000498A
Other languages
English (en)
Inventor
Elodie Klein
Veronique Graff
David Gilmer
Veronique Brault
Guy Weyens
Marc Lefebvre
Original Assignee
SESVanderHave NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44907563&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TN2013000498(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by SESVanderHave NV filed Critical SESVanderHave NV
Publication of TN2013000498A1 publication Critical patent/TN2013000498A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • C12N15/8283—Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance for virus resistance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Physiology (AREA)
  • Botany (AREA)
  • Developmental Biology & Embryology (AREA)
  • Environmental Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Cette invention concerne une séquence de nucléotides du virus BMYV P0 qui, une fois transcrite dans une cellule, est capable de former une séquence ARN double brin auto-complémentaire.
TNP2013000498A 2011-06-23 2013-11-27 Constructions d'extinction du gene p0 et utilisation TN2013000498A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP11171196A EP2537936A1 (fr) 2011-06-23 2011-06-23 Constructions de silençage du gène P0 et leur utilisation
PCT/EP2012/061436 WO2012175420A1 (fr) 2011-06-23 2012-06-15 Produits de recombinaison destinés à inactiver le gène p0 et leur utilisation

Publications (1)

Publication Number Publication Date
TN2013000498A1 true TN2013000498A1 (fr) 2015-03-30

Family

ID=44907563

Family Applications (1)

Application Number Title Priority Date Filing Date
TNP2013000498A TN2013000498A1 (fr) 2011-06-23 2013-11-27 Constructions d'extinction du gene p0 et utilisation

Country Status (17)

Country Link
US (2) US9932603B2 (fr)
EP (2) EP2537936A1 (fr)
CN (1) CN103635581B (fr)
CA (1) CA2839371A1 (fr)
CL (1) CL2013003466A1 (fr)
DK (1) DK2723873T4 (fr)
EA (1) EA029359B1 (fr)
ES (1) ES2647077T5 (fr)
HU (1) HUE035070T2 (fr)
LT (1) LT2723873T (fr)
MA (1) MA35283B1 (fr)
PL (1) PL2723873T5 (fr)
PT (1) PT2723873T (fr)
SI (1) SI2723873T1 (fr)
TN (1) TN2013000498A1 (fr)
UA (1) UA114603C2 (fr)
WO (1) WO2012175420A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150291969A1 (en) * 2014-01-30 2015-10-15 Chromatin, Inc. Compositions for reduced lignin content in sorghum and improving cell wall digestibility, and methods of making the same
CN110938645A (zh) * 2019-12-17 2020-03-31 中国农业大学 一种甘蔗黄叶病毒运动蛋白表达纯化方法及其多克隆抗血清的制备
US20230183733A1 (en) 2020-05-20 2023-06-15 KWS SAAT SE & Co. KGaA Multiple virus resistance

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE129745T1 (de) 1990-03-02 1995-11-15 Biocem Regenerierung und genetische transformation der zuckerrübe.
US7663024B2 (en) * 1998-07-10 2010-02-16 Sesvanderhave, N.V. P15 hairpin constructs and use
EP1029923A1 (fr) 1999-01-27 2000-08-23 D.J. Van Der Have B.V. Procédé conférant aux betteraves sucrières une résistance à une infection par BNYVV
WO2009141446A1 (fr) 2008-05-23 2009-11-26 Syngenta Participations Ag Plantes de betterave sucrière transgéniques
EP2367414A1 (fr) 2008-12-19 2011-09-28 Syngenta Participations AG Événement de betterave sucrière transgénique gm rz13

Also Published As

Publication number Publication date
HUE035070T2 (en) 2018-05-02
CN103635581A (zh) 2014-03-12
MA35283B1 (fr) 2014-07-03
DK2723873T4 (da) 2020-04-20
PL2723873T3 (pl) 2018-01-31
CA2839371A1 (fr) 2012-12-27
EA029359B1 (ru) 2018-03-30
SI2723873T1 (sl) 2017-11-30
ES2647077T3 (es) 2017-12-19
CL2013003466A1 (es) 2014-08-08
US20140317779A1 (en) 2014-10-23
DK2723873T3 (da) 2017-11-20
US9932603B2 (en) 2018-04-03
EP2723873A1 (fr) 2014-04-30
EP2723873B1 (fr) 2017-08-09
LT2723873T (lt) 2018-02-12
CN103635581B (zh) 2016-08-10
EP2537936A1 (fr) 2012-12-26
EP2723873B2 (fr) 2020-01-15
US10662438B2 (en) 2020-05-26
PT2723873T (pt) 2017-10-04
UA114603C2 (uk) 2017-07-10
PL2723873T5 (pl) 2020-07-13
ES2647077T5 (es) 2020-10-05
WO2012175420A1 (fr) 2012-12-27
US20180265888A1 (en) 2018-09-20
EA201490160A1 (ru) 2014-04-30

Similar Documents

Publication Publication Date Title
AU2018253578A1 (en) RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
TR201908969T4 (tr) Rnaı indüklü huntıngtın geni supresyonu.
JP2017093448A5 (fr)
BR112012025872A2 (pt) primidinas modificadas na posição-5 e seu uso
BRPI0819526B8 (pt) Sequência de ácido nucleico de precursor de mirna artificial, construção recombinante e método para reduzir a expressão de uma sequência alvo
WO2012024170A3 (fr) Inhibition médiée par des arn interférents de l'expression génique du virus de l'hépatite b (vhb) à l'aide de petits acides nucléiques interférents (pani)
AU2014219019A8 (en) Short interfering nucleic acid (siNA) molecules containing a 2' internucleoside linkage
EA201790420A1 (ru) Средства, представляющие собой модифицированную двухнитевую рнк
EA201391394A1 (ru) Композиции и способы ингибирования экспрессии генов вируса гепатита в
UA118014C2 (uk) Спосіб модифікації днк-мішені
WO2015024017A3 (fr) Arn polymérase, procédés de purification et procédés d'utilisation
WO2011008730A3 (fr) Modification chimique de petits arn en épingle à cheveux pour l'inhibition d'une expression de gène
EA201591229A1 (ru) Способы очистки матричной рнк
CA2792561C (fr) Compositions et procedes permettant d'inhiber l'expression du gene cd274/pd-l1
MX2021015290A (es) Composiciones y metodos para inhibicion de genes para apolipoproteina c-iii (apoc3).
WO2012093833A3 (fr) Ingéniérie des génomes faisant appel à des nucléases effectrices tal remodelées
AU2007240448A8 (en) Methods and compositions for expressing negative-sense viral RNA in canine cells
MX2014008454A (es) Acidos nucleicos de enlace c5a nuevos.
WO2012083969A3 (fr) Microarn pour le diagnostic du cancer du pancréas
WO2014066915A3 (fr) Procédés et compositions pour produire une activité ss-arni ayant une puissance accrue
UY34380A (es) ?determinación de polimorfismos de nucleótido simple útiles para predecir la respuesta clínica al acetato de glatirámero?.
WO2010107955A3 (fr) Inhibition médiée par arn interférence de l'expression génique de btb et de l'homologie cnc 1, facteur de transcription 1 de fermeture éclair de leucine basique (bach 1), utilisant une liste de séquences d'acide nucléique interférant court (ansi)
WO2012079046A3 (fr) Compositions et procédés d'inhibition de l'expression des gènes klf-1 et bcl11a
WO2013124807A3 (fr) Oligonucléotides pour moduler l'expression de gènes et leurs utilisations
TN2013000498A1 (fr) Constructions d'extinction du gene p0 et utilisation